Cargando…

RWD72 SARS-COV-2 Vaccine Breakthrough Infection Rates Based Data from 3 EHRS

Detalles Bibliográficos
Autores principales:	Overcash, J, Nguyen, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232782/ http://dx.doi.org/10.1016/j.jval.2022.04.1596

Ejemplares similares

Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination
por: Butt, Adeel A., et al.
Publicado: (2021)

SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders
por: Piñana, José Luis, et al.
Publicado: (2022)

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
por: Hacisuleyman, Ezgi, et al.
Publicado: (2021)

1594P SARS-CoV-2 vaccines in cancer patients (pts), real-world data (RWD) from 1069 Belong.life users
por: Sapir, E., et al.
Publicado: (2021)

Breakthrough SARS-CoV-2 Infections in Prison after Vaccination
por: Brinkley-Rubinstein, Lauren, et al.
Publicado: (2021)

Vaccine Breakthrough Infections of SARS-Cov-2: A Case Report
por: Kaswa, Ramprakash
Publicado: (2022)

Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

RWD-Cockpit: Application for Quality Assessment of Real-world Data
por: Babrak, Lmar Marie, et al.
Publicado: (2022)

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine
por: Mizrahi, Barak, et al.
Publicado: (2021)

SARS-CoV-2 vaccine antibody response and breakthrough infection in dialysis
por: Anand, Shuchi, et al.
Publicado: (2021)

How to Deal With Vaccine Breakthrough Infection With SARS-CoV-2 Variants
por: Guo, Ying, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina
por: Uschner, Diane, et al.
Publicado: (2022)

RWD-derived response in multiple myeloma
por: Xu, Tao, et al.
Publicado: (2023)

RWD111 Influenza Vaccine Sales During the COVID-19 Era
por: Ngami, A, et al.
Publicado: (2022)

RWD68 Characteristics/Comorbidities of Vaccinated and Unvaccinated Patients With COVID-19
por: Roy, A, et al.
Publicado: (2022)

RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD)
por: Kolbin, A, et al.
Publicado: (2022)

Emerging vaccine-breakthrough SARS-CoV-2 variants
por: Wang, Rui, et al.
Publicado: (2021)

Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination
por: Butt, Adeel A., et al.
Publicado: (2021)

Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers
por: Alishaq, Moza, et al.
Publicado: (2021)

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
por: Lipsitch, Marc, et al.
Publicado: (2021)

Breakthrough SARS-CoV-2 infections after vaccination: a critical review
por: Mohseni Afshar, Zeinab, et al.
Publicado: (2022)

Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
por: Zou, Jing, et al.
Publicado: (2022)

Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
por: Kared, Hassen, et al.
Publicado: (2022)

Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type
por: Dingemans, Jozef, et al.
Publicado: (2022)

Timing and implications for immune response to vaccine in SARS-CoV-2 breakthrough infections
por: Arsuffi, Stefania, et al.
Publicado: (2023)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
por: Regenhardt, Elisa, et al.
Publicado: (2023)

An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam
por: Chau, Nguyen Van Vinh, et al.
Publicado: (2021)

Vaccine breakthrough infections with SARS-CoV-2: Why older adults need booster vaccinations
por: Ventura, Maria I., et al.
Publicado: (2022)

Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
por: Servellita, Venice, et al.
Publicado: (2022)

RWD144 The Short Run and Long Run Behavioral Effects of COVID-19 Vaccination Enforcement
por: Baser, I., et al.
Publicado: (2023)

SARS-CoV-2 breakthrough infections in vaccinated kidney transplant recipients: an issue of concern
por: Wijtvliet, Veerle, et al.
Publicado: (2021)

SARS-CoV-2 variant surge and vaccine breakthrough infection: A computational analysis
por: Khater, Ibrahim, et al.
Publicado: (2022)

Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs
por: Dzinamarira, Tafadzwa, et al.
Publicado: (2022)

575. Local Experience of Breakthrough SARS-CoV-2 Infections After Full Vaccination
por: Khan, Ahmed A, et al.
Publicado: (2021)

A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
por: Zhang, Mengxin, et al.
Publicado: (2022)

Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
por: Hsu, L., et al.
Publicado: (2022)

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
por: Cortellini, Alessio, et al.
Publicado: (2022)

SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection
por: Baerends, Eva A.M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3knm3olv19i0pllvq4i3b66oco